Auro Laboratories Live BSE/NSE | Auro Laboratories Fundamenta data | Auro Laboratories Balance sheet | Auro Laboratories Quarterly Results | Auro Laboratories Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

52.63
12.15
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

56.62
N/A
2.30

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.14
7.48
9.70

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.62
18.91
9.60

PAT CAGR (%)

10 Years
5 Years
3 Years

49.29
40.63
75.07

P:E (Median)

8 Years
5 Years
3 Years

11.06
12.25
8.00

P:BV (Average)

8 Years
5 Years
3 Years

1.34
1.34
1.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.59
7.80
6.38

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 12 14 -11% 9 12 -18% 10 12 -22% 11 13 -12%
Expenses 10 12 -17% 9 9 -8% 8 10 -21% 9 11 -21%
EBITDA 2 2 31% 1 2 -65% 2 2 -29% 2 1 74%
EBIDTM 18% 12% 8% 18% 17% 18% 20% 10%
Other Income 0 0 -77% 0 1 -36% 0 0 57% 0 0 -15%
Interest 0 0 -50% 0 0 -23% 0 0 -44% 0 0 -42%
Depreciation 0 0 0% 0 0 5% 0 0 0% 0 0 0%
PBT 2 2 26% 1 2 -67% 1 2 -29% 2 1 92%
Tax 1 0 26% 0 1 -59% 0 0 -39% 1 0 119%
PAT 1 1 26% 0 2 -71% 1 1 -25% 1 1 80%
PATM 11% 8% 5% 14% 11% 11% 13% 6%
EPS 2.24 1.78 26% 0.75 2.55 -71% 1.67 2.23 -25% 2.33 1.29 81%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 42 47 41 35 28 33 34 44 25 20 11 Net Sales Growth -16% 15% 15% 27% -15% -3% -24% 74% 25% 78% Cost Of Goods Sold 23 29 25 22 18 23 25 35 19 16 8 Gross Profit 20 18 16 13 10 10 9 9 6 5 3 GP Margin 47% 39% 39% 37% 35% 30% 27% 21% 25% 24% 29% Total Expenditure 36 40 34 31 25 30 31 41 23 19 11 Power & Fuel Cost - 2 1 1 1 1 1 1 1 1 1 % Of Sales - 4% 4% 4% 4% 4% 4% 3% 2% 4% 5% Employee Cost - 3 3 3 2 2 2 2 2 1 1 % Of Sales - 6% 7% 8% 8% 7% 6% 4% 6% 7% 8% Manufacturing Exp. - 1 1 1 1 1 1 1 0 0 0 % Of Sales - 3% 3% 4% 4% 3% 3% 1% 2% 2% 3% General & Admin Exp. - 2 2 1 1 1 0 0 0 0 0 % Of Sales - 5% 5% 4% 3% 2% 1% 1% 1% 1% 4% Selling & Distn. Exp. - 2 1 1 1 2 1 2 1 0 0 % Of Sales - 4% 3% 3% 4% 5% 3% 3% 4% 2% 3% Miscellaneous Exp. - 1 1 1 1 0 0 0 0 0 0 % Of Sales - 2% 2% 3% 2% 1% 1% 1% 1% 0% 1% EBITDA 7 7 6 4 3 3 3 3 2 1 1 EBITDA Margin 16% 15% 16% 12% 10% 9% 8% 7% 8% 6% 6% Other Income 1 1 1 1 0 0 0 0 0 0 0 Interest 0 1 1 1 2 2 2 2 1 1 0 Depreciation 1 1 1 1 1 1 1 1 0 0 0 PBT 6 6 5 3 1 1 1 1 0 0 0 Tax 2 2 1 2 0 0 0 0 0 0 0 Tax Rate 28% 28% 25% 72% 0% 0% 0% 0% 0% 0% 0% PAT 4 4 4 1 1 1 1 1 0 0 0 PAT before Minority Interest 4 4 4 1 1 1 1 1 0 0 0 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 10% 9% 9% 2% 3% 2% 2% 2% 1% 1% 1% PAT Growth -11% 25% 330% -7% 10% 38% -25% 196% 24% 162% EPS 6.98 7.10 5.69 1.32 1.42 1.29 0.94 1.24 0.42 0.34 0.13

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

Net Sales Growth

-16%

15%

27%

-15%

-3%

-24%

74%

25%

78%

Cost Of Goods Sold

Gross Profit

GP Margin

47%

39%

37%

35%

30%

27%

21%

25%

24%

29%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

16%

15%

16%

12%

10%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

28%

25%

72%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

10%

PAT Growth

-11%

25%

330%

-7%

10%

38%

-25%

196%

24%

162%

EPS

6.98

7.10

5.69

1.32

1.42

1.29

0.94

1.24

0.42

0.34

0.13

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 17 13 9 9 8 7 6 6 5 5 Share Capital 6 6 6 6 6 6 6 6 6 6 Total Reserves 11 7 3 2 1 1 0 -1 -1 -1 Non-Current Liabilities 6 8 11 7 8 7 8 9 13 11 Secured Loans 3 3 5 0 0 0 1 1 6 5 Unsecured Loans 2 3 5 7 8 7 8 8 7 6 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 10 10 6 10 14 13 15 12 4 2 Trade Payables 5 5 5 4 4 4 6 5 3 2 Other Current Liabilities 1 1 1 1 1 1 1 1 1 0 Short Term Borrowings 4 3 0 5 9 7 8 6 0 0 Short Term Provisions 0 0 0 0 0 0 0 0 0 0 Total Liabilities 33 30 27 26 29 27 30 27 22 18 Net Block 15 13 13 9 10 11 11 6 7 5 Gross Block 23 21 20 16 15 15 15 10 10 8 Accumulated Depreciation 9 8 7 6 6 5 4 4 3 3 Non Current Assets 15 15 13 13 11 11 11 11 8 7 Capital Work in Progress 0 1 0 3 1 0 0 4 1 2 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 0 1 0 1 1 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 18 16 14 12 18 16 19 16 15 11 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 3 1 1 4 6 8 7 9 7 6 Sundry Debtors 8 8 8 5 8 4 8 3 4 3 Cash & Bank 4 2 1 1 0 1 0 0 1 1 Other Current Assets 2 3 2 2 3 2 3 3 3 2 Short Term Loans & Adv. 0 0 1 0 1 0 1 1 3 2 Net Current Assets 8 6 8 3 4 3 4 3 11 9 Total Assets 33 30 27 26 29 27 30 27 22 18

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

Share Capital

Total Reserves

-1

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 5 5 6 8 -1 4 1 2 0 0 PBT 6 5 3 1 1 1 1 0 0 0 Adjustment 2 2 2 2 2 2 2 2 1 1 Changes in Working Capital -1 -1 2 5 -4 2 -2 1 -2 -1 Cash after chg. in Working capital 7 6 6 8 -1 4 1 2 0 0 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -2 -1 -1 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -2 -2 -2 -2 -1 -1 -1 -4 -1 -2 Net Fixed Assets -2 -2 -1 -3 -1 -1 -1 -4 -1 -2 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 0 0 0 0 0 0 0 0 0 0 Cash from Financing Activity -2 -2 -4 -5 1 -3 -1 1 1 2 Net Cash Inflow / Outflow 2 1 0 0 -1 1 0 0 0 1 Opening Cash & Equivalents 2 1 1 0 1 0 0 1 1 0 Closing Cash & Equivalent 4 2 1 1 0 1 0 0 1 1

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

-1

PBT

Adjustment

Changes in Working Capital

-1

-4

-2

-1

Cash after chg. in Working capital

-1

Interest Paid

Tax Paid

-2

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-2

-1

-4

-1

-2

Net Fixed Assets

-2

-1

-3

-1

-4

-1

-2

Net Investments

Others

Cash from Financing Activity

-2

-4

-5

-3

-1

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 28 21 15 14 12 11 10 9 8 8 ROA 14% 12% 3% 3% 3% 2% 3% 1% 1% 0% ROE 29% 32% 9% 11% 11% 9% 13% 5% 4% 2% ROCE 29% 29% 20% 11% 11% 9% 12% 8% 8% 3% Fixed Asset Turnover 2.13 2.02 2.10 1.90 2.21 2.38 3.82 2.67 2.43 1.76 Receivable days 66 72 63 84 68 63 42 52 60 89 Inventory Days 19 13 28 61 71 74 62 112 109 166 Payable days 48 56 52 54 47 62 49 61 50 80 Cash Conversion Cycle 37 29 39 91 93 75 55 102 120 174 Total Debt/Equity 0.46 0.71 1.05 1.47 2.13 2.14 2.65 2.87 2.47 2.13 Interest Cover 8 5 3 2 1 1 1 1 1 1

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

ROA

14%

12%

ROE

29%

32%

11%

13%

ROCE

29%

20%

11%

12%

Fixed Asset Turnover

2.13

2.02

2.10

1.90

2.21

2.38

3.82

2.67

2.43

1.76

Receivable days

Inventory Days

112

109

166

Payable days

Cash Conversion Cycle

102

120

174

Total Debt/Equity

0.46

0.71

1.05

1.47

2.13

2.14

2.65

2.87

2.47

2.13

Interest Cover

Auro Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 530233 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Auro Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 530233 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update